Research led by Friedrich-Alexander-Universität Erlangen–Nürnberg provides evidence that teclistamab may offer therapeutic ...

Long-term follow-up shows 95% success rate, no serious complications in largest ADA-SCID gene therapy study to date ...

Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients ...

Working with an international team of collaborators, scientists at Columbia University have found a way to shift the balance ...

In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing ...

New research found that gene therapy for children with a form of severe combined immunodeficiency was successful in 95% of ...

Living with an autoimmune disease often means navigating a lifelong, complex condition. A recent study estimates that ...

MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while ...

Researchers at UCLA have developed a powerful new weapon in the battle against kidney cancer. Instead of relying on treatments tailored to each patient, this innovation uses specially engineered ...

The FDA adds a new boxed warning for immune effector cell-associated enterocolitis with Carvykti, but says the overall ...

Seoul, Seoul / / October 9, 2025 / Lydian Cosmetic Surgery Clinic Key Takeaways Stem cell therapy offers a minimally invasive ...

Japanese scientists successfully eliminated cancer tumors using live bacteria, a new therapy that acts independently of the immune system.